Susan Craddock, PhD

Acting Director, Center for Bioethics

Susan Craddock

Contact Info

craddock@umn.edu

Office Phone 612-624-8613

Fax 612-624-9108

Summary

My research asks questions about what shapes patterns of infectious diseases and the responses to them. Central to my work is how scientific research, commercial interest, health needs, and government policies interact to contour who experiences particular diseases, why, and how. My latest research for example looks at collaborations involved in what I am calling humanitarian pharmaceutical production – that is, nonprofit organizations, university researchers, pharmaceutical companies, and funding agencies researching new tuberculosis drugs and vaccines for the first time in several decades. What scientific, ethical, and regulatory innovations are emerging from these collaborations, and what constitutes the opportunities and challenges of producing new therapies outside of typical profit-making incentives, form key questions of this work. Compound Solutions: Pharmaceutical Alternatives for Global Health (University of Minnesota Press 2017) is the outcome of this research.

With my colleague Tamara Giles-Vernick, I've also looked at responses historically and currently to outbreaks of influenza, including controversies over global and national reactions to the recent H1N1 pandemic. Key points here were the variations in government response, the direct association between global inequality and vaccine access, evolving definitions of pandemic, and the growth of surveillance mechanisms for early detection. Before this, I examined the policies restricting availabilities of ARVs for the majority of people living with AIDS, a project that brought science, commerce, and suffering into direct conflict. In a related project I researched the politics of AIDS vaccine research, namely the design of clinical trials and the focus on developing vaccines against strains of HIV that primarily affect those in high income, not low income, countries.

Courses Taught

GWSS 8220: Feminist Science Studies

GWSS 5290/BTHX 5000: Health, Violence, and the State

GWSS 3290: The Politics of Pandemics

GLOS 3305: Life for Sale: Debates in Environment, Medicine, and Science

GWSS 3203: Blood, Bodies, and Science

HSEM 3305: Inequality and Global Health

Research

Publications

Compound Solutions: Pharmaceutical Alternatives for Global Health. University of Minnesota Press, 2017.

Making ties through making drugs: Partnerships for tuberculosis drug and vaccine development. In Global Health Geographies, Clare Herrick and David Reubi, CoEds., Routledge, 2016, 99-119.

Precarious connections: making therapeutic development happen for malaria and tuberculosis. Special Issue on One World One Health? Social Science Engagement with the One Health Agenda. Social Science and Medicine 2015, 129:36-43.

Introduction, Special Issue on One World One Health? Social Science Engagement with the One Health Agenda, coauthored with Steve Hichliffe. Social Science and Medicine 2015. 129:1-4.

Aid for Whom? Distance Caring and Corporate Practices. Special Issue on Brand Aid and the International Political Economy and Sociology of North-South Relations, co-editors Stefan Ponte and Lisa Richey, International Political Sociology Forum 2013. 1, 7:.98-101.

Critical interventions in global health geographies: Governmentality, risk, and assemblage, coauthored with Tim Brown and Alan Ingram. Special Issue on Geographies of Health, Ed. Dr. Mei Po Kwan; Annals of the Association of American Geographers 2012, 102,5:1182-1189

Drug Partnerships and Global Practices, Journal of Health and Place, 2012, 18, 3,2012.

Influenza and Public Health: Learning from Past Pandemics. Craddock, Susan, Tamara Giles-Vernick, Taylor and Francis, 2010.

The Politics of HIV/AIDS in Africa, in Peyi Soyinka-Airewele and Rita Kiki Edozie, Eds., Reframing Contemporary Africa, CQ, 2009.

Tuberculosis and the Anxieties of Containment, in Harris Ali and Roger Keil, Eds., Networked Diseases: Emerging Infections in the Global City, Wiley-Blackwell, 2008.

Market Incentives, Human Lives, and the AIDS Vaccine, Social Science and Medicine, 64, 5 1042-1056, 2007